Orris

Herpes simplex 1 and 2 IGg and IGm positive in pregnancy

Reading File
Finding Sources
Finding Sources
Searching PubMed

herpes simplex virus pregnancy management neonatal

Finding Sources
Reading Article
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Searching the Web

HSV IgG IgM positive pregnancy management interpretation 2024 guidelines

Reading File
Reading File
Finding Sources
Reading File
I now have comprehensive information to construct a thorough, evidence-based answer.

HSV-1 and HSV-2 IgG + IgM Positive in Pregnancy

Interpreting the Serology

When both IgG and IgM are positive for HSV-1 and/or HSV-2, the interpretation depends on clinical context:
IgGIgMInterpretation
PositiveNegativePast/latent infection (most common in pregnancy)
PositivePositiveReactivation OR recently acquired primary infection (IgM can persist or reappear with reactivation)
NegativePositiveEarly primary infection (window period - IgG not yet detectable)
Both negativeBoth negativeNo prior infection (seronegative - highest risk if exposed late in pregnancy)
Important caveat: HSV IgM is not reliable as a standalone test. It can be false-positive (cross-reactivity), can persist for months after primary infection, and can reappear during recurrences. PCR of a lesion or genital swab is far more clinically reliable for confirming active infection.
"The means to further refine management of asymptomatic neonates delivered to women with active genital HSV lesions now is possible" using type-specific IgG testing to classify maternal infection type. - Red Book 2021, p. 670

Maternal Infection Classification (Critical for Risk Assessment)

The Red Book Table 3.23 outlines the classification framework:
ClassificationGenital PCR/CultureHSV-1 & HSV-2 IgG Status
Primary (first episode, no prior exposure)Positive (either)Both negative
First-episode nonprimary (e.g., HSV-1 naive gets HSV-2)Positive HSV-2HSV-2 IgG negative, HSV-1 IgG positive
Recurrent infectionPositive for HSV-1 or -2IgG positive for same type
In the case where both IgG and IgM are positive for both HSV-1 and HSV-2, this most likely represents latent/recurrent disease - the patient has been previously infected with both strains and may be having a reactivation (reflected by IgM positivity).

Risks to the Pregnancy

The risk to the neonate is the central concern, not the mother:
  • Primary infection near delivery: 25-60% risk of neonatal transmission - the highest-risk scenario
  • Recurrent infection at delivery: Less than 2% transmission risk (due to transplacental IgG transfer providing partial protection)
  • Asymptomatic shedding at time of delivery is the source of infection in over 75% of neonatal HSV cases - mothers have no symptoms or known history
Neonatal HSV (incidence ~1 in 2,000 live births) presents as:
  1. Disseminated disease (25%) - liver, lungs, CNS involvement
  2. CNS disease (30%) - encephalitis, meningitis
  3. SEM disease (45%) - skin, eyes, mouth - best prognosis
  • Red Book 2021, p. 660-662

Management in Pregnancy

Antiviral Therapy

First-episode primary or nonprimary genital HSV:
  • Oral acyclovir (400 mg TID x 7-10 days) or valacyclovir (1 g BD x 7-10 days)
  • IV acyclovir if severe or requiring hospitalization
  • Famciclovir is not recommended in pregnancy
Recurrent genital HSV:
  • Suppressive therapy from 36 weeks gestation (or from 32 weeks in high-risk cases per the 2024 BASHH/RCOG update): Acyclovir 400 mg TDS or valacyclovir 500 mg BD
  • Goal: reduce viral shedding, reduce clinical recurrence at delivery, reduce cesarean delivery rate
  • Acyclovir has a strong safety record in pregnancy (Creasy & Resnik MFM, p. 1387)

Mode of Delivery

Active Lesions at Onset of Labor?Recommendation
Yes - primary or first episodeCesarean section (highest neonatal risk)
Yes - recurrentCesarean section strongly recommended
No lesions/prodrome at onset of labor (history of recurrent HSV)Vaginal delivery acceptable - the 2024 BASHH/RCOG guideline strengthens this recommendation
Membranes ruptured + HSV lesionsIndividualize; expedite delivery, IV acyclovir
Inspect the vulva carefully at the onset of all labors, not just those with known HSV history. - 2024 European Guidelines (IUSTI)

Prevention of Neonatal Transmission

  • Avoid invasive monitoring (fetal scalp electrode) in HSV-positive mothers when lesions present
  • Breastfeeding is safe if no breast lesions and other active lesions are covered
  • Anyone with active oral HSV or herpetic whitlow should avoid direct contact with the neonate

The Discordant Couple Scenario

If the partner is HSV-seronegative (discordant couple), there is a risk of primary acquisition in pregnancy, which carries the highest neonatal transmission risk. Strategies include:
  1. Complete abstinence from 26 weeks of pregnancy
  2. Consistent condom use
  3. Antivirals for the HSV-positive partner to suppress shedding
  4. Avoiding receptive orogenital contact (risk of acquiring HSV-1 genitally)

Summary: What to Do Clinically

  1. Confirm the clinical scenario - are there active lesions? What is the gestational age?
  2. Both IgG positive = prior infection with both HSV-1 and HSV-2 - classify as recurrent disease
  3. IgM positive - consider reactivation; correlate with symptoms; PCR lesion swab if present
  4. Offer suppressive acyclovir from 36 weeks (or 32 weeks if first-episode occurred in current pregnancy)
  5. Plan mode of delivery based on presence/absence of active lesions at onset of labor
  6. Counsel about neonatal risk and inform neonatology/pediatrics for delivery planning
  7. At delivery: careful vulval inspection; if lesions present with no prior IgG → highest risk → cesarean + IV acyclovir
Key references:
This is a shared conversation. Sign in to Orris to start your own chat.